Prevalência de carbapenemases em Pseudomonas aeruginosa em um hospital privado da cidade de Salvador, Bahia, Brasil

Ana Carolina Palmeira Arraes(Hospital São Rafael), Maria Goreth Barberino(Hospital São Rafael), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Thamires Gomes Lopes Weber(Hospital São Rafael), Lara Sbarro, Camila Araujo de Lourenzo Barcia, Gabriela Noronha Marques(Hospital São Rafael)

Unknown

January 1, 2024

10.5327/1516-3180.142s1.12406

Cited by 0

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

|The Lancet|2020|5k

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

|The Lancet|2021|1.2k

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

|The Lancet|2022|467

Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil

|Emerging infectious diseases|2021|215

Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial

|Biomedicine & Pharmacotherapy|2021|121